Aldeyra Therapeutics Reports Third-Quarter 2019 Financial Results and Provides Updates on Anticipated Clinical Milestones

Go back to Aldeyra Therapeutics Reports Third-Quarter 2019 Financial Results and Provides Updates on Anticipated Clinical Milestones
ALDEYRA THERAPEUT (NASDAQ: ALDX) Delayed: 1.82 -0.08 (4.21%)
Previous Close $1.90    52 Week High $8.19 
Open $1.94    52 Week Low $3.39 
Day High $1.96    P/E N/A 
Day Low $1.80    EPS $0.00 
Volume 663,319